Shares of biopharmaceutical company Axsome Therapeutics ( AXSM -6.29%) had declined 6% at 11 a.m. ET today. The slump comes after the company announced the results of a phase 3 trial of solriamfetol ...

There is some reason for optimism, but the risk of bad news coming also exists. Some of the latter is already priced into the ...

If you want to add an ETF to your portfolio, the Vanguard S&P 500 Growth Index Fund ETF ( VOOG -0.65%) could be a good ...

Rocket Lab USA ( RKLB -2.40%) stock has witnessed a nearly 400% appreciation over the last 12 months. So with regards to its business, which is the most important number investors should be keeping an ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Once retirement starts, you shouldn't be withdrawing as much as you need from your retirement coffers, hoping they'll last.

So while Ethereum used to be responsible for 96% of the TVL in DeFi protocols, that's now down to 53%. And while Ethereum was ...

Demand for artificial intelligence chips should continue to grow.

While tariffs, inflation, and soft consumer spending could weigh on Amazon stock in the near term, there are three reasons it ...

However, PayPal remains extremely profitable. It produced $6.8 billion in free cash flow (FCF) in the last 12 months, and ...

At its current price, Nio stock is the cheapest it's ever been, trading at an only 0.8 times price-to-sales (P/S) ratio against its five-year average P/S of 2.5. That's a dirt cheap price to pay for ...